Ionis Pharmaceuticals: Q3 loss but revenue beats forecasts
FROM THE WIRE · FINANCE.YAHOO.COM
CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Monday reported a loss of $110 million in its third quarter. The Carlsbad, California-based company said it had a loss of 66 cents per share. Losses, adjusted for stock option expense, were 40…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralMixed results: a wider net loss but revenue above estimates.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Ionis reported a third-quarter loss of $110 million.
- 02Loss per share was 66 cents, or 40 cents adjusted for stock option expense.
- 03Revenue of $243 million topped the $178.9 million estimate.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets